Im­mu­ni­ty­Bio looks to pull in $157M from founder Patrick Soon-Sh­iong and an­oth­er in­vestor

On­ly days af­ter win­ning nine fig­ures from an ar­bi­tra­tor in its long-run­ning case with Sor­ren­to Ther­a­peu­tics, Im­mu­ni­ty­Bio is look­ing to tap the fi­nan­cial well that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER